GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » 10-Year ROIIC %

Fresenius Medical Care AG (Fresenius Medical Care AG) 10-Year ROIIC % : -0.31% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Fresenius Medical Care AG's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was -0.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Fresenius Medical Care AG's 10-Year ROIIC % or its related term are showing as below:

FMS's 10-Year ROIIC % is ranked worse than
60.07% of 571 companies
in the Healthcare Providers & Services industry
Industry Median: 3.58 vs FMS: -0.31

Fresenius Medical Care AG 10-Year ROIIC % Historical Data

The historical data trend for Fresenius Medical Care AG's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG 10-Year ROIIC % Chart

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.09 3.93 2.13 -0.32 -0.31

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 - - - -0.31

Competitive Comparison of Fresenius Medical Care AG's 10-Year ROIIC %

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG's 10-Year ROIIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's 10-Year ROIIC % falls into.



Fresenius Medical Care AG 10-Year ROIIC % Calculation

Fresenius Medical Care AG's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 1141.701991 (Dec. 2023) - 1503.4865556 (Dec. 2013) )/( 33708.956 (Dec. 2023) - 20327.431 (Dec. 2013) )
=-361.7845646/13381.525
=-2.70%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Fresenius Medical Care AG  (NYSE:FMS) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Fresenius Medical Care AG 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors

Fresenius Medical Care AG (Fresenius Medical Care AG) Headlines